ARDX(Ardelyx, Inc.) · 财务报表

ARDX(Ardelyx, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$10.10M$52.16M$124.46M$333.62M$407.32M
毛利润$9.10M$48.04M$106.66M$283.06M$367.78M
营业利润−$154.35M−$63.76M−$63.28M−$27.95M−$40.98M
净利润−$158.16M−$67.21M−$66.07M−$39.14M−$61.60M
经营现金流−$152.55M−$70.04M−$89.72M−$44.81M−$42.48M
自由现金流−$154.42M−$70.10M−$90.06M−$45.82M−$43.98M
摊薄每股收益$-1.52$-0.42$-0.30$-0.17$-0.26

Ardelyx, Inc. ARDX